DE3468683D1 - 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide - Google Patents

2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide

Info

Publication number
DE3468683D1
DE3468683D1 DE8484108507T DE3468683T DE3468683D1 DE 3468683 D1 DE3468683 D1 DE 3468683D1 DE 8484108507 T DE8484108507 T DE 8484108507T DE 3468683 T DE3468683 T DE 3468683T DE 3468683 D1 DE3468683 D1 DE 3468683D1
Authority
DE
Germany
Prior art keywords
tetrazol
benzamide
formylamino
amino
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484108507T
Other languages
German (de)
English (en)
Inventor
Norton P Peet
Shyam Sunder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3468683D1 publication Critical patent/DE3468683D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Materials For Photolithography (AREA)
  • Paints Or Removers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DE8484108507T 1983-07-22 1984-07-18 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide Expired DE3468683D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/517,086 US4567193A (en) 1983-07-22 1983-07-22 2-(Formylamino)-N-(1H-tetrazol-5-yl)benzamide and use as anti-allergics

Publications (1)

Publication Number Publication Date
DE3468683D1 true DE3468683D1 (de) 1988-02-18

Family

ID=24058297

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484108507T Expired DE3468683D1 (de) 1983-07-22 1984-07-18 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide

Country Status (18)

Country Link
US (1) US4567193A (da)
EP (1) EP0132788B1 (da)
JP (1) JPS6042372A (da)
KR (1) KR890000663B1 (da)
AT (1) ATE31925T1 (da)
AU (1) AU564328B2 (da)
CA (1) CA1220210A (da)
DE (1) DE3468683D1 (da)
DK (1) DK159775C (da)
ES (1) ES534533A0 (da)
GR (1) GR82100B (da)
HU (1) HU191432B (da)
IE (1) IE57584B1 (da)
IL (1) IL72430A (da)
NO (1) NO168642C (da)
NZ (1) NZ208934A (da)
PT (1) PT78931B (da)
ZA (1) ZA845517B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879295A (en) * 1986-09-27 1989-11-07 Sawai Pharmaceutical Co., Ltd. N-tetrazolyl thiazolecarboxyamide derivatives and their use
DE3864248D1 (de) * 1987-12-14 1991-09-19 Sawai Seiyaku Kk Carboxamide mit tetrazol- und thiazol-ringen und ihre anwendung.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
CH630619A5 (en) * 1978-01-01 1982-06-30 May & Baker Ltd New derivatives of N-(5-tetrazolyl)benzamide

Also Published As

Publication number Publication date
JPH0369347B2 (da) 1991-10-31
IL72430A (en) 1987-11-30
GR82100B (da) 1984-12-13
IE841893L (en) 1985-01-22
DK358484A (da) 1985-01-23
EP0132788B1 (en) 1988-01-13
PT78931A (en) 1984-08-01
AU564328B2 (en) 1987-08-06
ZA845517B (en) 1985-03-27
DK159775C (da) 1991-05-06
EP0132788A1 (en) 1985-02-13
AU3052784A (en) 1985-01-24
HU191432B (en) 1987-02-27
HUT34460A (en) 1985-03-28
DK358484D0 (da) 1984-07-20
ES8601164A1 (es) 1985-10-16
IE57584B1 (en) 1993-01-13
ATE31925T1 (de) 1988-01-15
CA1220210A (en) 1987-04-07
PT78931B (en) 1986-09-08
KR890000663B1 (ko) 1989-03-22
IL72430A0 (en) 1984-11-30
KR850001182A (ko) 1985-03-16
NZ208934A (en) 1987-01-23
JPS6042372A (ja) 1985-03-06
NO168642C (no) 1992-03-18
ES534533A0 (es) 1985-10-16
NO842968L (no) 1985-01-23
DK159775B (da) 1990-12-03
NO168642B (no) 1991-12-09
US4567193A (en) 1986-01-28

Similar Documents

Publication Publication Date Title
FI881103A0 (fi) Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
SE8301008D0 (sv) Pyrrolacetic amide having antiinflammatory activity
NO924949L (no) Piperidylsubstituerte indoler
DE3468683D1 (de) 2-(formylamino)-n-(1h-tetrazol-5-yl)benzamide
ES519005A0 (es) Procedimiento para preparar 3-(1h-tetrazol-5-il)-4 (3 h)-quinazolinonas.
ES534532A0 (es) Un procedimiento para preparar derivados de benzamida.
SE8601963D0 (sv) O-sulfated beta-lactam hydroxamic acids
DE3674060D1 (de) Pharmacologisch aktive propionylanilide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERRELL PHARMACEUTICALS INC. (N.D.GES.D. STAATES D